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Previous studies measuring the health-related quality of life (HRQoL) of individuals with den-
gue focused on treatment seeking populations. However, the vast majority of global dengue
cases are unlikely to be detected by health systems. Representative measurements of
HRQoL should therefore include patients with disease not likely to trigger treatment-seeking
behavior. This study based in Iquitos, Peru used the Quality of Wellbeing Scale-Self Admin-
istered, a survey that enquires about not only physical health, but also psychological health,
self-care, mobility, and usual social activities, and rates HRQoL between 0 (death) and 1
(optimum function), to evaluate the impact of dengue on HRQoL. In order to enroll treatment
and non treatment-seeking participants, three modalities of participant recruitment were
used. In addition to clinic and community-based febrile surveillance, a contact-cluster meth-
odology was also employed to identify infected individuals less likely to seek treatment. We
measured changes in HRQoL and identified common areas of health impairment in 73 viro-
logically confirmed dengue cases at 3 time points during the participant’s illness; the early-
acute (days 0–6 post symptom onset), late-acute (days 7–20), and convalescent illness
phases (days 21 +). Participants reported HRQoL related impairments at significantly higher
frequency during the early-acute versus convalescent illness phase (Fisher’s exact:
P<0.01). There was substantial heterogeneity in scores during each illness phase with
median scores in the early-acute, late-acute and convalescent phases of 0.56 (IQR: 0.41–
0.64), 0.70 (IQR: 0.57–0.94), and 1 (IQR: 0.80–1.00), respectively. In all illness phases
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participants recruited in clinics had on average the lowest HRQoL scores where as those
recruited in the contact clusters had the highest. Only 1 individual who was recruited in the
contact-clusters had no reduction in HRQoL score during their illness. These data illustrate
that dengue should be considered as a disease that may have significant implications for
not only physical health but also psychological health and social functioning. The impact of
dengue on the HRQoL of non-treatment-seeking individuals, although lower than the impact
among treatment-seeking individuals, is not necessarily trivial.
Author summary
Dengue, a viral illness occurring following the bite of an infected mosquito, is common in
tropical urban areas of the globe. Using a survey that enquires about not only physical
health but also psychological health, self-care, mobility and usual social activities, this
study assesses the overall impact of dengue on the well-being of those with the disease. Of
the estimated 390 million annual infections, approximately 75 percent do not cause indi-
viduals to attend medical facilities, possibly because many infections do not result in sig-
nificant symptoms or because access to healthcare is limited. Unlike previous studies, this
study recruited those who would have been unlikely to seek healthcare as well as individu-
als who attended health facilities. This study adds to the growing body of evidence that
healthcare professionals should regard dengue as a disease that affects not only physical,
but also psychological health and aspects of social functioning. Furthermore, it suggests
that those not seeking treatment may also have a substantial reduction in quality of life
during their infection. Given the millions of dengue infected people who do not attend
healthcare facilities annually this could amount to a very meaningful societal impact.
Introduction
Dengue is a viral illness caused by one of four distinct serotypes of dengue virus (DENV) that
are transmitted primarily by Aedes aegypti mosquitoes. It is a major global public health con-
cern particularly in populated urban areas in the tropics [1,2]. Approximately 12 to 25% of the
estimated 390 million annual global DENV infections are apparent, manifesting as a febrile ill-
ness with sufficient severity to alter an individual’s regular activity [3,4]. Symptomatic infec-
tion usually lasts 2 to 7 days and is characterized by fever accompanied by headache, fatigue,
rash, and musculoskeletal pain [5]. Hospitalization rates for dengue in the Americas are
reported as 11% with approximately 10,000 annual deaths globally [3,6].
Although literature describing the symptoms of dengue is abundant, a holistic understand-
ing of the impact of dengue on an individual’s overall well-being also requires consideration of
its effects on psychological health and social functioning (such as mobility and self-care),
which are less well documented [7–10]. Herein, we will use the term health-related quality of
life (HRQoL) to describe this multidimensional concept of ‘overall health’, although in the lit-
erature various largely interchangeable terms are used including quality of life and quality of
well-being [11]. There are numerous non-disease-specific validated scales used to measure
HRQoL, most commonly applied in the context of chronic disease [12].
Though limited in number, studies have shown that the reduction in HRQoL associated
with dengue is a consequence not only of the physical symptoms, but also its impact on cogni-
tion, mood, interpersonal relationships and self-care [8–10]. In addition to improving our
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understanding of the holistic effects of a disease, studies of HRQoL may also be used to esti-
mate disease burden. This approach uses the measured reduction in HRQoL during the course
of an illness to determine the amount of healthy life lost during an illness episode. The values
can in turn be used to estimate disability adjusted life years (DALYs), a measure of the years of
healthy life lost due to a certain illness in a given population [13]. A recent systematic analysis
by Zeng et al used empirical data from 6 studies to estimate the disease burden of a single, non-
fatal dengue episode [14]. The authors concluded that previous measures may have underesti-
mated the disease burden of non-fatal dengue with the average episode of dengue being
responsible for the loss of 0.032 years of healthy life [3]. As these studies only recruited individ-
uals who actively sought treatment, individuals with less severe symptoms and those who can-
not access health facilities were excluded, an important limitation [9,14].
The prospective recruitment of non treatment-seeking individuals requires community-
based strategies that enroll individuals prior to them attending health facilities. One such strat-
egy is community febrile surveillance, where a cohort of individuals is monitored regularly
and tested for dengue at the onset of symptoms. However, this approach excludes individuals
that do not meet the threshold for inclusion (those with the mildest symptoms). To overcome
this problem both geographic and contact-cluster strategies screen individuals at higher risk of
infection prior to the onset of symptoms, based on their proximity (geographically or socially)
to a symptomatic ‘index’ case [15,16]. This enables the potential recruitment of dengue positive
individuals who may ultimately manifest any level of disease severity, including those who
would not seek treatment. A number of cohort studies have successfully used location and
contact-based cluster methods to recruit DENV infected individuals in the community who
would be unlikely to seek healthcare, yet to our knowledge none have measured HRQoL in
enrolled participants [15,16].
This study was part of a larger investigation based in the dengue endemic city of Iquitos,
Peru that used clinic, community and contact-cluster based illness surveillance to recruit
DENV-infected individuals from across the illness severity spectrum including those who
would be less likely to seek treatment [17]. In this component of the study we applied a vali-
dated HRQoL survey to dengue participants addressing the following objectives: 1) describe
the impact of dengue on physical and psychological health, as well as aspects of social wellbe-
ing, 2) quantify the impact of dengue on HRQoL and describe how HRQoL changed over the
course of dengue, and 3) determine the magnitude of the effect of each recruitment method on
dengue-related changes in HRQoL.
Methodology
Ethics statement
The study protocol was approved by the Naval Medical Research Unit No. 6 (NAMRU-6)
Institutional Review Board (IRB) (protocol #NAMRU6.2014.0028), in compliance with all
applicable Federal regulations governing the protection of human subjects. IRB relying agree-
ments were established between NAMRU-6, the University of California, Davis, Tulane Uni-
versity, Emory University and the University of California, San Diego. The protocol was
reviewed and approved by the Loreto Regional Health Department, which oversees health
research in Iquitos. Adults� 18 years and parents or legal guardians of participants�17 years
of age provided written informed consent or assent as appropriate.
Field site
Data collection took place in the city of Iquitos, located in the Loreto Department of the Peru-
vian Amazon. The city is surrounded by three rivers; the Itaya, Nanay, and Amazon and is
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accessible only by plane or boat. According to the latest census, Iquitos has a population of
approximately 400,000 with the principal industries being oil, fishing, lumber, tourism, and
agriculture [17,18]. In 2016 more than 60% of the department population relied on govern-
ment health insurance, which covers those living in poverty and extreme poverty [19]. Autoch-
thonous transmission of all four DENV serotypes has been reported in Iquitos since 1990, with
DENV2 currently being the predominant circulating serotype [18]. Zika virus was also intro-
duced into Iquitos during late 2016 and circulated until the end of 2017 [20]. There are numer-
ous publications covering approximately two decades of dengue-related epidemiological and
entomological studies in Iquitos [18,21,22].
Study design
We relied on 3 mechanisms for recruitment of study participants. The first two mechanisms
were clinic-based passive surveillance [23] and community-based active surveillance [24]. Pos-
itive cases identified through either clinic or community-based surveillance were then used to
initiate the third mechanism, active surveillance based on a contact-cluster design [16].
Clinic-based passive illness surveillance: Project nurses based at two Ministry of Health hos-
pitals or seven health centers in and around Iquitos were responsible for enrolling clinic-based
participants. Residents aged 5 years and older who presented with undifferentiated fever
(� 38˚C or reported use of antipyretics) for 5 days or less were offered a blood test to diagnose
dengue using real-time polymerase chain reaction (RT-PCR). Individuals with virologically
confirmed DENV infections were then invited to participate in prospective disease
monitoring.
Community-based active illness surveillance: A team of nurses and phlebotomists recruited
community-based participants in a cohort of greater than 25,000 residents from approximately
4,000 households in two neighborhoods in Iquitos. Houses were visited three times per week
and residents were briefly asked about fever and other symptoms of dengue. Residents meeting
the same criteria as clinic-based participants described above were invited to participate.
Contact-cluster active surveillance: A field team member experienced in dengue contact
tracing visited DENV-positive participants recruited in either clinic-based or community-
based surveillance. At this visit a retrospective movement survey was administered to DENV
positive participants to determine locations visited in the previous 15 days [25]. Residential
sites identified were visited and household members over 5 years were invited to provide an
initial blood sample for RT-PCR testing; however, if another active case was detected in the
initial samples then repeat samples were requested from all contacts at an interval of no less
than 2 days. This methodology has been shown to facilitate the identification of asymptomatic
or pre-symptomatic DENV infected individuals [16]. Positive individuals were invited to
participate.
Data collection
Participants were visited by the research team daily during the acute phase of illness until
symptoms had resolved, and again 30 days after enrollment. Study physicians reviewed all
DENV positive participants and could be contacted by field workers should subsequent medi-
cal advice be needed. The QWB-SA was one of a number of surveys administered to partici-
pants during their illness. The other surveys were a daily symptom survey, two surveys to
capture participant movements, a sociodemographic survey and a survey assessing disease-
related expenses.
The QWB-SA is a comprehensive measure of HRQoL that like the original QWB survey, is
a preference-based measure of HRQoL that produces a single, summary score ranging from 0
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(dead) to 1 (optimum function) and allows for the calculation of Quality-Adjusted Life Years
(QALYs) [26]. Symptoms and functional limitations that are endorsed as present are multi-
plied by preference weights obtained in a large community sample [26]. The survey includes 8
principal sections, each with a varying number of questions (S1 Table and S1 Text). Sections 1
and 2 (total 43 questions) address physical symptoms. Section 3 (14 questions) addresses men-
tal health symptoms. Section 4 is a single open-ended question enquiring about any other
symptoms not already reported. Section 5 (2 questions) addresses whether help was needed
with self-care. Section 6 (3 questions) addresses mobility. Section 7 (8 questions) considers
physical functioning. Section 8 (3 questions) addresses usual social activity.
The QWB-SA has been used with a variety of chronic diseases, such as musculoskeletal and
mental health disorders and epilepsy [23]. Although the application of this tool to dengue (an
acute infectious disease) is novel, the QWB-SA was selected because it addresses common den-
gue symptoms and its questions focus on the three days preceding survey completion, which is
an appropriate temporal scale for the course of dengue symptoms. The survey has substantially
more questions than other HRQoL surveys (EuroQol and WHOQOL-BREF) previously used
in dengue studies, and therefore we reasoned that its broader question coverage might help to
capture subtle changes in HRQoL [8,26–28]. We created a digital version of the Spanish
QWB-SA survey using CommCare, an open source, cloud-based platform that provides a
framework for developing mobile data collection systems [29]. This tool was piloted by our
research team, and a small number of linguistic modifications specific to Iquitos were made to
the questions. The survey was then administered by experienced local field workers using a
digital mobile device on day 3 and 7 post diagnosis and at day 30 to serve as a proxy for base-
line HRQoL.
Completed surveys were uploaded to the CommCare Server and reviewed for data entry
errors by senior project members. If necessary, data corrections were made using the Comm-
Care HQ website data correction facility. Final versions of the completed surveys were then
imported into a PostgreSQL database and anonymized survey data were sent to the University
of California-San Diego where the QWB-SA algorithm was applied to each survey to generate
the HRQoL score [26].
Forms were assigned a ‘day of illness’ (DOI), which indexes surveys by the number of days
post symptom onset that they were acquired. The DOI was calculated by subtracting the date
of symptom onset from the date one day prior to survey administration. DOI 0, therefore, rep-
resents the day symptoms started and, because contacts could be diagnosed prior to symptom
onset, the DOI could be a negative value. Because the questions in the QWB-SA refer to the
three days prior to the interview day, we regarded the survey as having referred to the DOI cor-
responding to the day before the interview. Surveys were then grouped into 1 of 3 illness
phases: 1) surveys completed up to and including DOI 6 were assigned to the ‘early-acute
phase’, 2) surveys from DOI 7 to 20 were assigned to the ‘late-acute phase’ and 3) surveys com-
pleted after DOI 20 were assigned to the ‘convalescent phase’ of illness.
We present results of individual questions from the QWB-SA in the following 5 groups;
Physical symptoms (Sections 1 and 2), psychological symptoms (Section 3), self-care (Section
5), mobility and physical functioning (Sections 6 and 7) and usual social activity (Section 8).
Section 1 and 2 have been combined as they both represent physical symptoms, Sections 6 and
7 are combined as these both relate strongly to mobility. For display purposes we used abbrevi-
ated versions of the questions and where necessary clarify the exact nature of the question in
the text. See S1 Table for details of grouping and abbreviations.
All statistical analyses were carried out in R version 3.5.1 [30]. Basic descriptive statistics
were calculated for baseline characteristics using means and standard deviations if variables
were normally distributed, or medians and interquartile ranges for non-normally distributed
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variables. To assess for differences in responses between illness phases, the proportion of indi-
viduals responding affirmatively to all questions was calculated for each of the three illness
phases. Comparisons of proportions were made using Fisher’s exact tests between illness
phases. Due to the large number of comparisons a Bonferroni correction was applied to the
alpha value transforming alpha levels of 0.05 and 0.01 to 0.0007 and 0.0001, respectively. As
HRQoL scores were non-normally distributed, to analyze differences in HRQoL scores
between illness phases and recruitment methodology we carried out Wilcoxon rank-sum tests
for pairwise comparisons and Kruskal-Wallis tests for comparisons of more than two groups.
To further quantify changes in HRQoL over time and to evaluate the effects of important
independent variables on HRQoL score, we considered a mixed-effects regression model
using HRQoL score as the dependent variable. Independent variables in this model included
the following fixed effects: (1) DOI, to measure the effect of the time course of illness; (2) par-
ticipant recruitment method, to assess how the three different recruitment methods may sam-
ple from intrinsically different populations, with the expectation that those recruited by
community-based active illness surveillance and contact-cluster active surveillance would have
higher HRQoL scores than those recruited in the clinic-based surveillance; (3) Sex, as differing
roles within in the household might affect HRQoL and could have important social implica-
tions, and (4) Age, as a continuous variable, as evidence suggests that the likelihood of symp-
tomatic disease is affected by age [31]. We also included a random intercept by participant to
account for repeated measures by person. As the HRQoL score (dependent variable) could
take on values only between 0 and 1 we transformed the variable with a logit link function
after applying a small adjustment to move values away from both 0 and 1 to prevent the occur-
rence of infinite values following transformation, this is called a logit normal regression. We
then created a linear mixed effects regression model using the lmer function from the ‘lme4’
and ‘lmerTest’ packages in R [32]. Finally, we tested the significance of the random effect by
participant by comparing models with and without the random effect using the likelihood
ratio test. Analogously to an odds ratio for a logistic regression we report all results in terms of
a “score ratio” (SR) which here is the score divided by one minus the score. Although not the
primary purpose of this model we then used the model predicted scores to calculate the disease
burden of an acute dengue episode in order to make comparisons with other similar reports in
the literature. To do this we calculated the model predicted loss of HRQoL for the first 20 days
of illness by subtracting predicted HRQoL scores for each day from 1 and adding these values
together. This number represents the estimated number of healthy days lost to dengue in the
first 20 days of illness. To complete the calculation, we divided this number by 365.25 to con-




Table 1 summarizes baseline characteristics of the study participants (See S2 Table that sum-
marizes data from only individuals who completed a survey in each illness phase). There were
73 DENV-positive participants contributing a total of 195 QWB-SA surveys. Of these 73 par-
ticipants, 12 were recruited in clinics or hospitals by passive surveillance, 42 in the commu-
nity-cohort by active surveillance and 19 in contact clusters. A total of 7 participants were
hospitalized (at least one night spent as an inpatient) of which 1 was recruited by clinic-based
surveillance, 5 by community-based surveillance, and 1 by contact-cluster surveillance. Fifty-
six of the 73 participants completed 3 QWB-SA surveys, 10 completed 2 surveys and 7 com-
pleted 1 survey. Fifty of the 56 participants who completed 3 surveys completed a single survey
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in each illness phase. Of all participants recruited in the clinics, only 50% (6) went on to com-
plete 3 surveys, compared to 81% (34) of those recruited in the community and 84% (16)
recruited in the contact-clusters. Pairwise comparisons between these percentages were not
statistically significant (Fisher’s exact test p>0.05).
The age and sex distribution of those recruited from the community and contact-clusters
was similar. The percentage of women recruited from clinic surveillance was non-significantly
greater than from both the community surveillance (Fisher’s exact test p = 0.20) and the con-
tact-clusters (Fisher’s exact test p = 0.48). The age of those recruited from the clinics was signif-
icantly greater than from community (Wilcoxon test p<0.01) and non-significantly greater
than from contact-clusters (Wilcoxon test p = 0.08). Participants from the clinics and commu-
nity had experienced a similar number of days of symptoms at recruitment, differences were
small and non-significant (Wilcoxon test p = 0.73). However, participants from the contact-
clusters were recruited after significantly less days of symptoms compared to both clinic partic-
ipants (Wilcoxon test p<0.01) and community participants (Wilcoxon test p<0.01).
Responses by illness phase
Early-acute versus convalescent phase: A significantly greater proportion of affirmative
responses were recorded in 22 questions in the early-acute versus the convalescent illness
phase (Fisher’s exact: P<0.05). Eleven of these were physical symptoms, including fever, head-
ache and fatigue; 4 were psychological symptoms, anorexia, insomnia, feeling upset and
nervousness; 4 related to mobility, including being bedbound, avoiding walking and difficulty
bending and carrying items; 3 related to social activity and included an effect on school/work,
an effect on personal life and a need to change plans for health reasons (Fig 1). All of these 22
responses showed a declining trend across the 3 illness phases, illustrated in Fig 1 by the color
gradient from left to right. Heatmaps that include all questions by each recruitment mode can
be seen in S1–S4 Figs. A paired analysis of individuals who completed 1 survey in each illness
phase revealed very similar patterns (S5 Fig).
Late-acute versus convalescent phase: Affirmative responses that continued to be reported
in significantly higher frequency in the late-acute compared with the convalescent phase (Fish-
er’s exact: P<0.05) included fever, insomnia, an effect on school/work and an effect on per-
sonal life. Notably, the only response reported in significantly higher frequency in the late-
Table 1. Participant characteristics.
Characteristic All Clinic Community Cluster
Number of participants 73 12 42 19
Number of surveys 195 27 115 53
Sex (%)
Male 37 (51) 4 (33) 24 (57) 9 (47)
Female 36 (49) 8 (67) 18 (43) 10 (53)
Median age (IQR) 17 (13–27) 25 (19–39) 16 (13–18) 15 (11–33.5)
Median symptom duration in days (IQR)� 2 (1–3) 2.5 (1–3) 3 (1–4) 1 (0–1)
Hospitalized (%) 7 (10) 1 (8) 5 (12) 1 (5)
Serotype (%)
DENV2 70 (96) 11 (92) 41 (98) 18 (95)
DENV3 3 (4) 1 (8) 1 (2) 1 (5)
�Median number of days of symptoms a participant had already experienced on the day the diagnostic blood sample was taken. S2 Table includes a version that contains
data from individuals who completed a survey in each illness phase.
https://doi.org/10.1371/journal.pntd.0008477.t001
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acute versus convalescent phase that was not also significantly elevated in the early-acute phase
was being hospitalized (spending any part of the day or night as a patient in a hospital, nursing
home, or rehabilitation center). The most frequent responses reported in the convalescent
phase of illness were headache (7/59), itching (7/59), fatigue (5/59), abdominal pain (including
upset stomach, abdominal pain, nausea, heartburn, or vomiting) (5/59) and anxiety (5/59).
The paired analysis revealed that only an effect on personal life was reported in significantly
higher frequency in the late-acute versus convalescent phase (S5 Fig). S3 Table also shows a
comparison between the early-acute and late-acute illness phases.
HRQoL score by illness phase (Table 2 and Fig 2)
The HRQoL scores were lowest in the early-acute phase of illness and showed improvement
over the 3 illness phases with median scores in the early-acute, late-acute and convalescent
phases of 0.56, 0.70 and 1.00, respectively. This trend was maintained in a paired analysis of
the 50 participants who provided QWB-SA surveys in all 3 illness phases with median scores
in the acute, early-acute, chronic phases of 0.52, 0.75 and 1.00, respectively (S4 Table, S6 Fig).
In both the non-paired and paired analyses, the differences between early-acute and conva-
lescent scores and between late-acute and convalescent scores were significant (Wilcoxon:
P<0.01). Of the 50 individuals who provided scores in all 3 illness phases there was substantial
Fig 1. Heatmap: Proportion of participants reporting symptoms or effects by illness phase (left column: early-acute, middle column:
late-acute, right column: convalescent phase). The proportion is represented by the redness of the cell and the actual proportion is shown by
the number in each cell. � Fisher’s exact test: P<0.05, �� Fisher’s exact test: P<0.01. This includes only symptoms that were reported in
significantly higher frequency in the early-acute or late-acute versus the convalescent phase of illness.
https://doi.org/10.1371/journal.pntd.0008477.g001
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heterogeneity in the differential between a participant’s maximum and minimum scores, with
a mean difference of 0.42 (SD 0.137). Of these 50 participants all had maximum scores of
greater than 0.6, 40 had maximum scores greater than 0.8 and 34 had maximum scores of 1,
implying that the majority of individuals had good baseline HRQoL. The median minimum
HRQoL scores in these 50 participants was 0.49 (IQR 0.41–0.6). The trend of improving
HRQoL scores was maintained when data was grouped by both sex and age. Although the
numbers of individuals within each of these subgroups were small the differences were statisti-
cally significant (Kruskal-Wallis P<0.05), except for females in the 18 to 53-year age group.
Multiple regression analysis (Table 3 and Fig 3)
The likelihood ratio test (LRT) comparing models with and without a random effect by partici-
pant found the random effect to non-significantly affect the model performance (P = 0.138);
we therefore selected the model without the random effect. Although it could be argued due to
the repeated measures by participant that selecting the model with a random effect by partici-
pant would be more appropriate regardless of the results of the LRT, the model coefficients are
very similar and thus we chose the simpler of the two models.
In our final model, day of illness was found to have a significant positive association with
HRQoL (SR:1.08/day, CI:1.06–1.10). When compared to the contact-cluster modality of cap-
ture both community-based (SR:0.34, CI:0.18–0.62) and clinic-based (SR:0.26, CI:0.11–0.63)
surveillance were found to have significant negative association with HRQoL. Age had a signif-
icant negative association with HRQoL score (SR:0.96/year, CI:0.94–0.98). Male sex had a
non-significant positive association with HRQoL (SR:1.09, CI:0.65–1.85).
The predicted burden (years of healthy life lost) in the first 20 days of a single episode of
dengue in a male of age 16 years recruited in the clinic, community and clusters was 0.015
(95% CI: 0.008–0.024), 0.012 (0.009–0.017) and 0.005 (0.003–0.008), respectively. These values
are graphically represented by the shaded areas bound by the black dashed line in Fig 3.
Discussion
In this study we describe the impact of dengue on the HRQoL of infected individuals. We have
shown that the impairment of HRQoL in dengue is a function not only of its impact on physi-
cal, but also psychological health and aspects of social well-being. These results are consistent
Table 2. HRQoL Scores by illness phase and recruitment mode.
recruitment phase forms participants median score (IQR�) range
All Early-acute 69 65 0.56 (0.41–0.64) 0.25–1.00
Late-acute 67 65 0.70 (0.57–0.94) 0.26–1.00
Convalescent 59 59 1.00 (0.80–1.00) 0.39–1.00
Clinic Early-acute 12 12 0.40 (0.29–0.46) 0.25–0.68
Late-acute 9 9 0.70 (0.55–0.81) 0.26–1.00
Convalescent 6 6 0.77 (0.74–0.81) 0.62–1.00
Community Early-acute 37 36 0.58 (0.41–0.65) 0.26–0.93
Late-acute 42 40 0.70 (0.57–0.87) 0.36–1.00
Convalescent 36 36 1.00 (0.81–1.00) 0.39–1.00
Contact Early-acute 20 17 0.60 (0.49–0.75) 0.26–1.00
Late-acute 16 16 0.74 (0.63–1.00) 0.44–1.00
Convalescent 17 17 1.00 (0.93–1.00) 0.48–1.00
�IQR: Interquartile range
https://doi.org/10.1371/journal.pntd.0008477.t002
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with three previous HRQoL studies in treatment-seeking dengue participants in Malaysia, Bra-
zil and Vietnam [8–10]. During the acute phase of illness, typical physical symptoms of dengue
were accompanied by nervousness and feelings of upset. The disease similarly had a number of
effects on mobility and both personal and professional social activity that persisted into the
late-acute phase of the illness. The 4 most common symptoms recorded in the convalescent
phase (headache, itching, fatigue and anxiety) are similar to those in previous reports of persis-
tent symptoms in dengue [33,34]. This information is of value to healthcare professionals man-
aging dengue as it reinforces the importance of providing a holistic clinical assessment and
draws attention to the potential impact of the disease beyond the febrile phase of the illness. By
Fig 2. HRQoL score by illness phase Box and whisker plots demonstrate the distribution of HRQoL scores in each illness phase, dark horizontal
line = median, upper limit of box = 75th percentile, lower limit box = 25th percentile, upper whisker extends to the largest value< = 1.5 multiplied x IQR,
lower whisker extends to the smallest value> = 1.5 x IQR. Red dots represent individual scores. They are partially transparent and therefore appear darker where
multiple points overlay each other. A: Un-paired analysis of all participants regardless of recruitment mode or the number of surveys completed, � Wilcoxon:
P<0.05, �� Wilcoxon: P<0.01. B: Paired analysis of only participants who completed a single survey in each illness phase regardless of recruitment � Wilcoxon:
P<0.05, �� Wilcoxon: P<0.01. C: Un-paired analysis comparing recruitment modes within each illness phase � Wilcoxon: P<0.05, �� Wilcoxon: P<0.01. D: Un-
paired analysis comparing illness phases within each recruitment mode � Wilcoxon: P<0.05, �� Wilcoxon: P<0.01. Paired versions of C & D can be seen in S6 Fig.
https://doi.org/10.1371/journal.pntd.0008477.g002
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directly enquiring about symptoms of anxiety and the social consequences of dengue such as a
reduced earning capacity, healthcare professionals could be prompted to direct patients to
additional support such as mental health services. These lessons can also be applied to the
Table 3. Model comparison.
Independent variables Fixed effects model e Mixed effects model
SR (95% CI) SR (95% CI)
(Intercept)a 9.54 (4.54–20.07) 9.41 (4.24–20.93)
Day of illness 1.08 (1.06–1.10) 1.08 (1.06–1.10)
Recruitment: community-basedb 0.34 (0.18–0.62) 0.33 (0.17–0.65)
Recruitment: clinic-basedb 0.26 (0.11–0.63) 0.26 (0.10–0.66)
Age 0.96 (0.94–0.98) 0.96 (0.94–0.98)
Sex: Malec 1.09 (0.65–1.85) 1.09 (0.62–1.94)




a: Intercept Score ratio when all independent variables set to zero or (default if categorical) i.e. Day of illness = 0,
Recruitment = contact-cluster, Age = 0 and Sex = female
b: Default = contact-cluster.
c: Default = female.
d: Likelihood ratio test comparing model performance between the 2 models. P-value of 0.138 suggests there is no
significant difference between model performance.
e Selected model. Model fixed effects score ratios (SR) and 95% confidence intervals (CI).
https://doi.org/10.1371/journal.pntd.0008477.t003
Fig 3. HRQoL by day of illness and recruitment modality Multiple regression analysis predicted HRQoL scores (y-axis) by day of illness
(x-axis) and recruitment modality (individual panels). Individual points represent actual measured HRQoL scores. Thick colored lines
represent model predicted scores and faint lines represent +/-2 x standard error. As the model included age as a continuous variable, we
graphed predicted scores for the median age of 16 years and as the differences in sexes was negligible and non-significant, we only represent
males. Shaded areas represent predicted healthy life lost due to a dengue episode. Black dashed lines enclose the proportion of healthy life lost
within the first 20 days of illness.
https://doi.org/10.1371/journal.pntd.0008477.g003
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population level ensuring that the appropriate resources, particularly in an outbreak scenario,
are available to tackle the varied impacts of this disease.
We quantified the impact of dengue on HRQoL over the course of the illness showing that
the HRQoL score is lowest during the acute illness phase and that there is a marked improve-
ment in scores over the course of dengue. Although this pattern was the same for all recruit-
ment modes, we showed that the magnitude of the reduction in HRQoL was associated with
recruitment modality, where those recruited in the clinics tended to see the greatest reduction
in HRQoL and those in the contact-clusters the least (Figs 2 and 3). The clinic recruited group
was also notable for its older age than the other recruitment groups. Older age could poten-
tially lead to lower HRQoL due to concurrent co-morbidities (we did not record these in this
study). However, when adjusting for age using our multiple regression analysis, we show that
clinic recruitment was still associated with a lower HRQoL score indicating that other factors
are also involved. Overall these findings suggest that, as expected, those who seek treatment
tend to be most adversely affected by dengue.
There was marked variation in the HRQoL scores in our entire study population and in the
acute illness phase the range of scores was greatest in those recruited in the contact-clusters
(Fig 2) where one individual had no reduction in HRQoL and one individual was ultimately
hospitalized. This variation of HRQoL scores suggests that we sampled from a more heteroge-
nous population than previous studies, with treatment and non treatment-seeking individuals
included. We cannot label all participants as treatment or non treatment-seeking because the
study intervention may have altered the behavior of those recruited in the community and
contact-clusters as advice given to participants by study staff could have affected whether indi-
viduals attend a medical facility or not. It is tempting to assume that those with least impact on
HRQoL represent those who would not have sought treatment. Whilst this is almost certainly
true for the one individual who showed no reduced HRQoL during his illness, individuals
experiencing a substantial reduction in HRQoL may not attend health facilities due to barriers
to healthcare access such as financial factors and proximity [35]. We recruited only a single
DENV positive individual who experienced no impairment in HRQoL during their infection
despite it being stated that approximately 75% of DENV infections are inapparent. This dis-
crepancy may indicate that the QWB-SA tool was sensitive enough to detect even small reduc-
tions in HRQoL that may not be detected by other measures of disease impact. However, an
alternative interpretation is that the morbidity amongst individuals with infections regarded as
inapparent is less trivial than assumed [4,9]. Whilst our data do not confirm this hypothesis,
further support comes from cluster studies in children based in Thailand that reveal very few
children reported no symptoms [36].
Another way to assess the impact of dengue on HRQoL is through the estimation of a dis-
ease burden metric such as DALYs. Using empirical data from 6 studies, Zeng et al, estimated
that the first 20 days of a single episode of dengue are responsible for the loss of 0.012 years of
healthy life [14]. Although the prediction of HRQoL scores was not the primary purpose of
our multiple regression analysis using our model-predicted scores for males of the median age
(16yrs) we calculated estimated DALYs for the first 20 days of a dengue episode for clinic,
community and contact-cluster recruited participants. Whilst DALYs for clinic and commu-
nity recruited participants were similar to the results of Zeng et al (0.015, 0.012), the contact-
cluster group showed a substantially smaller DALY (0.005), again highlighting a greater disease
heterogeneity in our entire study population and the presence of cases with a relatively smaller
impact on HRQoL.
We would expect the impact of dengue on HRQoL scores in our study population to be less
than in studies of only treatment-seeking populations. However, comparison of HRQoL scores
between studies is complicated by methodological differences and differing study populations.
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The Malaysian and Brazilian studies used a visual analog scale (VAS) from the EuroQol survey
that asks participants to place a mark on a ruler from 0 (worst health imaginable) to 100 (best
health imaginable) indicating how they feel on that day [8,9,28]. In contrast the Vietnamese
study used the EuroQol’s five-dimensional survey that enquires about each of the following;
mobility, self–care, usual activities, pain/discomfort, and anxiety/depression [10]. A validated
algorithm is then used to convert these responses into a HRQoL score [28]. Direct compari-
sons of the scores is further complicated by the differing timings of the data collection. The
Malaysian study gathered data at 2 interviews asking participants to recall the impact of the
disease on days that they were not interviewed for approximately 20 days. The Brazilian study
took a similar approach but only performed a single interview at 15 days after symptom onset.
The Vietnamese study does not clearly state when the interview occurred in relation to the dis-
ease onset.
The intention of using 3 recruitment modalities was to recruit a broader range of subjects.
Although our results show that this was the case it is important to point out that each recruit-
ment mode was subject to different selection biases. Clinic surveillance selects only those par-
ticipants who can access a medical facility and those with symptoms severe enough to prompt
treatment-seeking behavior. Thus, it is likely that those with milder symptoms will be under
represented in this group. Community surveillance does enable recruitment of those who
might not have access to healthcare facilities, but still only selects those who develop symptoms
that meet the surveillance criteria. Contact-clusters overcome this problem by screening peo-
ple whether or not they have specific symptoms. Nonetheless, participants in this group are
selected based on their proximity to a symptomatic index case potentially meaning they too
are more likely to develop symptoms due to, for example those in the same family may have
similar immunological response to the illness due to genetic homogeneity. Whilst neither our
total sample nor any of the three individual recruitment groups are likely to represent is to be
representative of the 390 million dengue cases occurring globally, we have sampled partici-
pants with a broader spectrum of illness severity than other studies of HRQoL in dengue. We
have shown that the findings from studies in treatment-seeking individuals should not be
extrapolated to non treatment-seeking population.
We acknowledge a number of limitations in this study. We did not collect true baseline
HRQoL data and although the majority of our participants (34/50) reported near perfect
HRQoL at the follow-up interview, for those that did not we are unsure if the residual issues
represented the persistent effects of dengue or baseline health issues. Future work would aim
to take this into account and administer a retrospective pre-illness survey for comparison.
Finally, compared to other HRQoL studies in dengue the sample size here is relatively small;
73 versus 372 in the Brazilian study and 207 in the Malaysian study [8,9]. This may have led to
insufficient power to detect significant differences in some of the statistical comparisons. One
of the principal reasons for reduced participant numbers was the introduction of Zika virus
midway through this study during late 2016 at which time DENV transmission largely ceased
[20]. However, unlike most publications we present data from multiple time points per partici-
pant enabling analysis of the trends of HRQoL scores over time. Although other publications
did collect multiple data points these were collected retrospectively at a maximum of 2 inter-
views with the potential for substantial recall bias [8,9].
In summary, through the novel application of the QWB-SA we add to the growing body of
evidence that dengue should be considered as a disease that may have significant implications
for not only physical health but also psychological health and social functioning and that these
health impairments may extend beyond the febrile period. These data illustrate the significant
impact of dengue on HRQoL in a population that includes non-treatment seeking individuals,
a previously understudied group. The findings suggest that measurements of HRQoL in
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treatment-seeking populations should not be extrapolated to non treatment-seeking groups
and that the impact of dengue on the HRQoL of non-treatment seeking individuals, although
lower than the impact among treatment seeking individuals, is not necessarily trivial. Further
work to expand and improve the recruitment of non-treatment seeking individuals would
enable a clearer distinction between these groups and contribute to a better understanding of
impact of dengue on HRQoL in these groups.
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